Revolution Medicines, Inc. financial data

Symbol
RVMD, RVMDW on Nasdaq
Location
Redwood City, CA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 25 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 951% % -38%
Debt-to-equity 31% % 159%
Return On Equity -63% % -89%
Return On Assets -48% % -61%
Operating Margin -88032% % -6144%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 198,173,397 shares 6.4%
Common Stock, Shares, Outstanding 197,001,401 shares 6%
Entity Public Float $6,700,000,000 USD 3.1%
Common Stock, Value, Issued $19,000 USD 5.6%
Weighted Average Number of Shares Outstanding, Basic 190,129,154 shares 13%
Weighted Average Number of Shares Outstanding, Diluted 190,129,154 shares 13%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $0 USD -100%
Research and Development Expense $987,332,000 USD 67%
General and Administrative Expense $195,037,000 USD 100%
Operating Income (Loss) $1,182,369,000 USD -71%
Nonoperating Income (Expense) $51,068,000 USD -42%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $1,131,301,000 USD -88%
Income Tax Expense (Benefit) $753,000 USD 79%
Net Income (Loss) Attributable to Parent $1,131,301,000 USD -89%
Earnings Per Share, Basic -5.95 USD/shares -66%
Earnings Per Share, Diluted -5.95 USD/shares -66%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $383,745,000 USD -29%
Marketable Securities, Current $1,641,934,000 USD -6%
Assets, Current $2,075,037,000 USD -11%
Property, Plant and Equipment, Net $33,194,000 USD 37%
Operating Lease, Right-of-Use Asset $132,084,000 USD 12%
Intangible Assets, Net (Excluding Goodwill) $55,800,000 USD -1.5%
Goodwill $14,608,000 USD 0%
Other Assets, Noncurrent $14,779,000 USD 748%
Assets $2,354,508,000 USD -8%
Accounts Payable, Current $64,616,000 USD 19%
Accrued Liabilities, Current $5,000,000 USD
Liabilities, Current $290,424,000 USD 77%
Deferred Income Tax Liabilities, Net $2,353,000 USD 0%
Operating Lease, Liability, Noncurrent $142,234,000 USD 16%
Other Liabilities, Noncurrent $1,208,000 USD 80%
Liabilities $723,211,000 USD 147%
Accumulated Other Comprehensive Income (Loss), Net of Tax $3,237,000 USD 145%
Retained Earnings (Accumulated Deficit) $2,869,102,000 USD -65%
Stockholders' Equity Attributable to Parent $1,631,297,000 USD -28%
Liabilities and Equity $2,354,508,000 USD -8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $194,435,000 USD -21%
Net Cash Provided by (Used in) Financing Activities $874,000 USD 7.9%
Net Cash Provided by (Used in) Investing Activities $15,949,000 USD 94%
Common Stock, Shares Authorized 300,000,000 shares 0%
Common Stock, Shares, Issued 197,001,401 shares 6%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $209,510,000 USD 49%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $388,603,000 USD -29%
Deferred Tax Assets, Valuation Allowance $928,511,000 USD 65%
Deferred Tax Assets, Gross $982,394,000 USD 61%
Operating Lease, Liability $158,702,000 USD 17%
Depreciation $7,400,000 USD 19%
Payments to Acquire Property, Plant, and Equipment $3,266,000 USD 3.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $1,129,385,000 USD -88%
Lessee, Operating Lease, Liability, to be Paid $239,095,000 USD 11%
Property, Plant and Equipment, Gross $61,707,000 USD 34%
Operating Lease, Liability, Current $16,468,000 USD 28%
Lessee, Operating Lease, Liability, to be Paid, Year Two $20,210,000 USD 19%
Lessee, Operating Lease, Liability, to be Paid, Year One $21,044,000 USD 16%
Operating Lease, Weighted Average Discount Rate, Percent 0.0797 pure 4%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $76,323,000 USD 3.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three $21,861,000 USD 25%
Deferred Tax Assets, Operating Loss Carryforwards $435,594,000 USD 92%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $59,542,000 USD -71%
Lessee, Operating Lease, Liability, to be Paid, Year Four $22,626,000 USD 28%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $870,000 USD -19%
Deferred Tax Assets, Net of Valuation Allowance $53,883,000 USD 19%
Share-based Payment Arrangement, Expense $118,389,000 USD 49%
Preferred Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%